LifeSignals has received CE mark approval for the LifeSignals ECG Remote Monitoring Patch, a disposable wireless remote monitoring system, intended for use by healthcare professionals for continuous collection of Electrocardiography (ECG) and heart rate monitoring in ambulatory, hospital, healthcare and home settings.
Patient data can be transmitted wirelessly throughout the care continuum with high reliability from the LifeSignals Patch, to a secure cloud-based platform, LifeSignals said in a press release. Healthcare professionals can remotely access this data and rapidly make treatment decisions independent of patient location. The interoperable device can be integrated into most clinical workflows, including Remote Patient Monitoring systems, Mobile Cardiac Telemetry systems, Holter and Event Monitoring Systems, the press release added.
“This CE Mark approval of LifeSignals’ next generation wireless technology-based patch, represents a major step forward in our drive to “untether” patient monitoring systems,,” said Surendar Magar, co-founder and CEO of LifeSignals. “With the integration of the LifeSignals Patch, clinically-accurate patient data can be captured inexpensively and sent to existing medical monitoring systems or cloud-based systems for direct analysis. Healthcare professionals can make faster treatment decisions while patients can be confident of receiving data-driven personalised therapy.”
The LifeSignals Patch will be sold as a white-labelled device, marketed in Europe through a network of partnerships from OEMs and telehealth software providers to specialist hospital facilities. The patch is available immediately to interested partners. LifeSignals has also developed a cloud-based Holter Analysis platform, incorporating the use of LifeSignals patches, to facilitate the expansion of clinical remote ECG monitoring services.